aspect
of
drug)
→
ReceivesAction
→
determined
Typicality: | 0.647 |
Saliency: | 0.551 |
during clinical trials | 5 | temporal |
as with any supplement | 4 | other |
by testing it | 4 | manner |
effect → be → determined | 39 |
effect → be → measured | 34 |
effect → be → calculated | 4 |
negative | neutral | positive |
0.207 | 0.736 | 0.057 |
Raw frequency | 77 |
Normalized frequency | 0.551 |
Modifier score | 1.000 |
Perplexity | 204.436 |